218 Results

People

  1. Papanicolaou
    Papanicolaou
  2. Perales
    Perales
  3. Giralt
    Giralt
  4. Seo
    Seo
  5. Papadopoulos
    Papadopoulos
  6. Shaffer
    Shaffer
  7. Jakubowski
    Jakubowski
  8. Kernan
    Kernan
  9. Sepkowitz
    Sepkowitz
  10. Amar
    Amar

Groups

  1. Department of Medicine (112)
  2. Division of Subspecialty Medicine (53)
  3. Hematologic Malignancies, Division of (52)
  4. Center for Hematologic Malignancies (50)
  5. Survivorship Research (33)
  6. Bone Marrow Transplant (32)
  7. Infectious Disease (30)
  8. Surgery (27)
  9. Epidemiology and Biostatistics (23)
  10. Solid Tumor Oncology Division (22)
  1. "prophylaxis"
Formats
  1. Journal Article (190)
  2. Review (15)
  3. Guidelines (4)
  4. Research Letter (4)
  5. Correspondence (2)
  6. Conference Paper (1)
  7. Editorial (1)
  8. Meeting Abstract (1)
Groups
  1. Department of Medicine (112)
  2. Division of Subspecialty Medicine (53)
  3. Hematologic Malignancies, Division of (52)
  4. Center for Hematologic Malignancies (50)
  5. Survivorship Research (33)
  6. Bone Marrow Transplant (32)

More Groups

People
  1. Genovefa Papanicolaou (17)
  2. Miguel-Angel Perales (13)
  3. Sergio Giralt (12)
  4. Susan Seo (11)
  5. Brian Shaffer (8)
  6. Esperanza Papadopoulos (8)

More People

Years
  1. 2025 (11)
  2. 2024 (19)
  3. 2023 (15)
  4. 2022 (8)
  5. 2021 (8)
  6. 2020 (9)

More Years

Publications
  1. Biology of Blood and Marrow Transplantation (9)
  2. Transplantation and Cellular Therapy (9)
  3. Blood (7)
  4. Cancer (7)
  5. Journal of Clinical Oncology (6)
  6. Journal of the National Comprehensive Cancer Network (6)

More Publications

Publishers
  1. Elsevier Inc. (42)
  2. Wiley Blackwell (17)
  3. Elsevier Science, Inc. (12)
  4. American Society of Hematology (11)
  5. Lippincott Williams & Wilkins (11)
  6. Oxford University Press (11)

More Publishers

Results (218)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Management of patients with advanced prostate cancer. Report from the 2024 Advanced Prostate Cancer Consensus Conference (APCCC)
    Journal Article

    Gillessen, S.; Turco, F.; Davis, I. D.; Efstathiou, J. A.; Fizazi, K.; James, N. D.; Shore, N.; Small, E.; Smith, M.; Sweeney, C. J.; more...
    European Urology (2025)

    Fulltext@MSK | Save
  • Challenges and lessons learned in recruiting participants for school-based disease prevention programs during COVID-19
    Journal Article

    Wu, Y. P.; Brunsgaard, E. K.; Siniscalchi, N.; Stump, T.; Smith, H.; Grossman, D.; Jensen, J.; Buller, D. B.; Hay, J. L.; Shen, J.; more...
    Contemporary Clinical Trials Communications (2024)

    Fulltext@MSK | Save
  • Venous thromboembolism in adolescents and young adults with acute lymphoblastic leukemia treated on a pediatric-inspired regimen
    Journal Article

    Shimony, S.; Raman, H. S.; Flamand, Y.; Keating, J.; Paolino, J. D.; Valtis, Y. K.; Place, A. E.; Silverman, L. B.; Sallan, S. E.; Vrooman, L. M.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • Artificial intelligence enabled interpretation of ECG images to predict hematopoietic cell transplantation toxicity
    Journal Article

    Shaffer, B. C.; Brown, S.; Chinapen, S.; Mangold, K. E.; Lahoud, O.; Lopez-Jimenez, F.; Schaffer, W.; Liu, J.; Giralt, S.; Devlin, S.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • High-dose alemtuzumab and cyclosporine vs tacrolimus, methotrexate, and sirolimus for chronic graft-versus-host disease prevention
    Journal Article

    Holtzman, N. G.; Curtis, L. M.; Salit, R. B.; Shaffer, B. C.; Pirsl, F.; Ostojic, A.; Steinberg, S. M.; Schulz, E.; Wilder, J. S.; Hughes, T. E.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • A retrospective analysis of micafungin prophylaxis in children under 12 years undergoing chemotherapy or hematopoietic stem cell transplantation
    Journal Article

    Goscicki, B. K.; Yan, S. Q.; Mathew, S.; Mauguen, A.; Cohen, N.
    Journal of Pediatric Pharmacology and Therapeutics (2024)

    Fulltext@MSK | Save
  • The PI3Kδ inhibitor zandelisib on intermittent dosing in relapsed/refractory follicular lymphoma: Results from a global phase 2 study
    Journal Article

    Zelenetz, A. D.; Jurczak, W.; Ribrag, V.; Linton, K.; Collins, G. P.; Jiménez, J. L.; Bishton, M.; Dholaria, B.; Mengarelli, A.; Phillips, T. J.; more...
    HemaSphere (2024)

    Fulltext@MSK | Save
  • Anti-ceramide ScFv prophylaxis for first responders to a limited nuclear attack
    Journal Article

    Cheng, J.; Nagesh, P. K. B.; Feldman, R.; Shamu, T.; Zhang, Z.; Fuks, Z.; Kolesnick, R.
    Cellular Physiology and Biochemistry (2024)

    Fulltext@MSK | Save
  • Strategic infection prevention after genetically modified hematopoietic stem cell therapies: Recommendations from the International Society for Cell & Gene Therapy Stem Cell Engineering Committee
    Review

    John, T. D.; Maron, G.; Abraham, A.; Bertaina, A.; Bhoopalan, S. V.; Bidgoli, A.; Bonfim, C.; Coleman, Z.; DeZern, A.; Li, J.; more...
    Cytotherapy (2024)

    Fulltext@MSK | Save
  • Two novel assays demonstrate persistent daratumumab exposure in a pediatric patient with delayed engraftment following allogeneic hematopoietic stem cell transplantation
    Journal Article

    Major-Monfried, H.; Hosszu, K.; McAvoy, D. P.; Vallone, A.; Shukla, N.; Gillio, A.; Spitzer, B.; Kung, A. L.; Cancio, M.; Curran, K.; more...
    Cytotherapy (2024)

    Fulltext@MSK | Save